Home » Novartis Gains New Indication for Diovan in the EU
Novartis Gains New Indication for Diovan in the EU
The European Commission has granted Diovan (valsartan) a new pediatric indication for the treatment of hypertension in children and adolescents 6–18 years of age.
TradingMarkets
TradingMarkets
Upcoming Events
-
07May
-
14May
-
30May